Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan Des Guetz

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacyThierry Landre, Gaëtan Des Guetz
La Revue Du Praticien|December 5, 2018
Esophageal tumorsÉlise Deluche, Gaëtan Des Guetz
Gastroenterologie Clinique Et Biologique|January 27, 2006
[Chemotherapy and MSI status]Gaëtan des Guetz, Pierre-Olivier Schischmanoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Paraneoplastic syndromes in cancer: Case 2. Leucocytosis associated with liposarcoma recurrence: original presentation of liposarcoma recurrenceGaëtan des Guetz, Pascale Mariani, Paul Freneaux, et al.
Gastroenterologie Clinique Et Biologique|May 3, 2005
[NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]Gaëtan des Guetz, Robert Benamouzig, Stanislas Chaussade, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancerGaëtan Des Guetz, Bernard Uzzan, Jean-Francois Morere, et al.
Targeted Oncology|April 4, 2009
Microsatellite instability: a predictive marker in metastatic colorectal cancer?Gaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.
Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacyThierry Landre, Gaëtan Des Guetz
La Revue Du Praticien|December 5, 2018
Esophageal tumorsÉlise Deluche, Gaëtan Des Guetz
Gastroenterologie Clinique Et Biologique|January 27, 2006
[Chemotherapy and MSI status]Gaëtan des Guetz, Pierre-Olivier Schischmanoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Paraneoplastic syndromes in cancer: Case 2. Leucocytosis associated with liposarcoma recurrence: original presentation of liposarcoma recurrenceGaëtan des Guetz, Pascale Mariani, Paul Freneaux, et al.
Gastroenterologie Clinique Et Biologique|May 3, 2005
[NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis]Gaëtan des Guetz, Robert Benamouzig, Stanislas Chaussade, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancerGaëtan Des Guetz, Bernard Uzzan, Jean-Francois Morere, et al.
Targeted Oncology|April 4, 2009
Microsatellite instability: a predictive marker in metastatic colorectal cancer?Gaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.
Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.
Pageof 3